The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,6-Difluoro-3-((4-(4-methoxyphenyl)-5-oxo-1,3,4-oxadiazol-2-yl)methoxy)benzamide ID: ALA4566531
PubChem CID: 155560797
Max Phase: Preclinical
Molecular Formula: C17H13F2N3O5
Molecular Weight: 377.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-n2nc(COc3ccc(F)c(C(N)=O)c3F)oc2=O)cc1
Standard InChI: InChI=1S/C17H13F2N3O5/c1-25-10-4-2-9(3-5-10)22-17(24)27-13(21-22)8-26-12-7-6-11(18)14(15(12)19)16(20)23/h2-7H,8H2,1H3,(H2,20,23)
Standard InChI Key: DMVHBTNXZBPFRN-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
18.9690 -19.1992 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7862 -19.1992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0406 -18.4225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3776 -17.9403 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7189 -18.4225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1785 -17.1981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1774 -18.0177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8854 -18.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5951 -18.0172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5923 -17.1945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8836 -16.7893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2984 -16.7833 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.4707 -16.7897 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.8812 -15.9721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5877 -15.5614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1723 -15.5656 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3034 -18.4247 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0105 -18.0150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2658 -19.8608 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7435 -18.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4542 -18.4111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1566 -17.9964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1488 -17.1791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4326 -16.7783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7332 -17.1953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8518 -16.7625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5641 -17.1629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
10 12 1 0
6 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
9 17 1 0
17 18 1 0
18 5 1 0
2 19 2 0
3 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
26 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.30Molecular Weight (Monoisotopic): 377.0823AlogP: 1.79#Rotatable Bonds: 6Polar Surface Area: 109.58Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.96CX Basic pKa: ┄CX LogP: 2.18CX LogD: 2.18Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.70Np Likeness Score: -1.35
References 1. Bi F, Song D, Qin Y, Liu X, Teng Y, Zhang N, Zhang P, Zhang N, Ma S.. (2019) Discovery of 1,3,4-oxadiazol-2-one-containing benzamide derivatives targeting FtsZ as highly potent agents of killing a variety of MDR bacteria strains., 27 (14): [PMID:31200986 ] [10.1016/j.bmc.2019.06.010 ]